EQS-Adhoc
Kuros Biosciences to present at upcoming U.S. spine conferences
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Miscellaneous Schlieren (Zurich), Switzerland, 17 June, 2021 - Kuros Biosciences (SIX: KURN), a leader in next generation bone graft technologies and a pioneer in the emerging field of osteoimmunology, today announced that high-profile surgeons will present on the STRUCTURE clinical trial with Fibrin-PTH and on preclinical and clinical data for MagnetOs bone graft at the upcoming 16th annual meeting of the Korean American Spine Society, and at the Spine Summit 2021. Company management will also attend several U.S. clinical conferences in June, July and August. |
MagnetOs bone graft is supported by a growing set of preclinical data demonstrating equiva-lence to the current gold standard, autograft, with over three years of clinical experience since its first use in the UK in May 2017.
Details of the conferences are as follows:
-
55th Annual Meeting of the Rocky Mountain Neurosurgical Society
Jackson, WY, U.S.
June 19 - 23, 2021
-
16th Annual Meeting of the Korean American Spine Society
Carlsbad, CA, U.S.
July 1-3, 2021
Presenter: Dr. John H. Chi, MD, MPH
-
Spine Summit 2021 - The 37th Annual Meeting of the AANS/CNS Section on Disor-ders of the Spine and Peripheral Nerves
San Diego, CA, U.S.
July 28-31, 2021
Presenter: Dr. Alpesh. A. Patel, MD,
-
Texas Association of Neurosurgeons 2021 Annual Meeting
Bastrop, TX, U.S.
August 5-8, 2021
-
Augusta Spine Symposium
North Augusta, SC, U.S.
August 13, 2021
-
Michigan Association of Neurological Surgeons 39th Annual Meeting
Traverse City, MI, U.S.
Diskutieren Sie über die enthaltenen Werte